Nichole T Tanner1, Alexander Porter2, Michael K Gould3, Xiao-Jun Li2, Anil Vachani4, Gerard A Silvestri5. 1. Thoracic Oncology Research Group, Division of Pulmonary and Critical Care, Medical University of South Carolina, Charleston, SC; Health Equity and Rural Outreach Innovation Center, Ralph H. Johnson Veterans Affairs Hospital, Charleston, SC. Electronic address: tripici@musc.edu. 2. Integrated Diagnostics, Inc., Seattle, WA. 3. Kaiser Permanente Southern California, Pasadena, CA. 4. Pulmonary, Allergy, and Critical Care Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 5. Thoracic Oncology Research Group, Division of Pulmonary and Critical Care, Medical University of South Carolina, Charleston, SC.
Abstract
BACKGROUND: The annual incidence of pulmonary nodules is estimated at 1.57 million. Guidelines recommend using an initial assessment of nodule probability of malignancy (pCA). A previous study found that despite this recommendation, physicians did not follow guidelines. METHODS: Physician assessments (N = 337) and two previously validated risk model assessments of pretest probability of cancer were evaluated for performance in 337 patients with pulmonary nodules based on final diagnosis and compared. Physician-assessed pCA was categorized into low, intermediate, and high risk, and the next test ordered was evaluated. RESULTS: The prevalence of malignancy was 47% (n = 158) at 1 year. Physician-assessed pCA performed better than nodule prediction calculators (area under the curve, 0.85 vs 0.75; P < .001 and .78; P = .0001). Physicians did not follow indicated guidelines when selecting the next test in 61% of cases (n = 205). Despite recommendations for serial CT imaging in those with low pCA, 52% (n = 13) were managed more aggressively with PET imaging or biopsy; 12% (n = 3) underwent biopsy procedures for benign disease. Alternatively, in the high-risk category, the majority (n = 103 [75%]) were managed more conservatively. Stratified by diagnosis, 92% (n = 22) with benign disease underwent more conservative management with CT imaging (20%), PET scanning (15%), or biopsy (8%), although three had surgery (8%). CONCLUSIONS: Physician assessment as a means for predicting malignancy in pulmonary nodules is more accurate than previously validated nodule prediction calculators. Despite the accuracy of clinical intuition, physicians did not follow guideline-based recommendations when selecting the next diagnostic test. To provide optimal patient care, focus in the areas of guideline refinement, implementation, and dissemination is needed. Published by Elsevier Inc.
BACKGROUND: The annual incidence of pulmonary nodules is estimated at 1.57 million. Guidelines recommend using an initial assessment of nodule probability of malignancy (pCA). A previous study found that despite this recommendation, physicians did not follow guidelines. METHODS: Physician assessments (N = 337) and two previously validated risk model assessments of pretest probability of cancer were evaluated for performance in 337 patients with pulmonary nodules based on final diagnosis and compared. Physician-assessed pCA was categorized into low, intermediate, and high risk, and the next test ordered was evaluated. RESULTS: The prevalence of malignancy was 47% (n = 158) at 1 year. Physician-assessed pCA performed better than nodule prediction calculators (area under the curve, 0.85 vs 0.75; P < .001 and .78; P = .0001). Physicians did not follow indicated guidelines when selecting the next test in 61% of cases (n = 205). Despite recommendations for serial CT imaging in those with low pCA, 52% (n = 13) were managed more aggressively with PET imaging or biopsy; 12% (n = 3) underwent biopsy procedures for benign disease. Alternatively, in the high-risk category, the majority (n = 103 [75%]) were managed more conservatively. Stratified by diagnosis, 92% (n = 22) with benign disease underwent more conservative management with CT imaging (20%), PET scanning (15%), or biopsy (8%), although three had surgery (8%). CONCLUSIONS: Physician assessment as a means for predicting malignancy in pulmonary nodules is more accurate than previously validated nodule prediction calculators. Despite the accuracy of clinical intuition, physicians did not follow guideline-based recommendations when selecting the next diagnostic test. To provide optimal patient care, focus in the areas of guideline refinement, implementation, and dissemination is needed. Published by Elsevier Inc.
Authors: S J Swensen; M D Silverstein; E S Edell; V F Trastek; G L Aughenbaugh; D M Ilstrup; C D Schleck Journal: Mayo Clin Proc Date: 1999-04 Impact factor: 7.616
Authors: Peter J Mazzone; Xiao-Feng Wang; Yaomin Xu; Tarek Mekhail; Mary C Beukemann; Jie Na; Jonathan W Kemling; Kenneth S Suslick; Madhu Sasidhar Journal: J Thorac Oncol Date: 2012-01 Impact factor: 15.609
Authors: M E J Callister; D R Baldwin; A R Akram; S Barnard; P Cane; J Draffan; K Franks; F Gleeson; R Graham; P Malhotra; M Prokop; K Rodger; M Subesinghe; D Waller; I Woolhouse Journal: Thorax Date: 2015-08 Impact factor: 9.139
Authors: Alex A Balekian; Gerard A Silvestri; Suzanne M Simkovich; Peter J Mestaz; Gillian D Sanders; Jamie Daniel; Jackie Porcel; Michael K Gould Journal: Ann Am Thorac Soc Date: 2013-12
Authors: Anil Vachani; Harvey I Pass; William N Rom; David E Midthun; Eric S Edell; Michel Laviolette; Xiao-Jun Li; Pui-Yee Fong; Stephen W Hunsucker; Clive Hayward; Peter J Mazzone; David K Madtes; York E Miller; Michael G Walker; Jing Shi; Paul Kearney; Kenneth C Fang; Pierre P Massion Journal: J Thorac Oncol Date: 2015-04 Impact factor: 15.609
Authors: Nichole T Tanner; Jyoti Aggarwal; Michael K Gould; Paul Kearney; Gregory Diette; Anil Vachani; Kenneth C Fang; Gerard A Silvestri Journal: Chest Date: 2015-12 Impact factor: 9.410
Authors: Michael N Kammer; Dianna J Rowe; Stephen A Deppen; Eric L Grogan; Alexander M Kaizer; Anna E Barón; Fabien Maldonado Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-09-02 Impact factor: 4.090
Authors: Roger Y Kim; Jason L Oke; Lyndsey C Pickup; Reginald F Munden; Travis L Dotson; Christina R Bellinger; Avi Cohen; Michael J Simoff; Pierre P Massion; Claire Filippini; Fergus V Gleeson; Anil Vachani Journal: Radiology Date: 2022-05-24 Impact factor: 29.146
Authors: Francys C Verdial; David K Madtes; Guang-Shing Cheng; Sudhakar Pipavath; Richard Kim; Jesse J Hubbard; Megan Zadworny; Douglas E Wood; Farhood Farjah Journal: Chest Date: 2019-12-17 Impact factor: 9.410
Authors: Xiaonan Cui; Marjolein A Heuvelmans; Daiwei Han; Yingru Zhao; Shuxuan Fan; Sunyi Zheng; Grigory Sidorenkov; Harry J M Groen; Monique D Dorrius; Matthijs Oudkerk; Geertruida H de Bock; Rozemarijn Vliegenthart; Zhaoxiang Ye Journal: Transl Lung Cancer Res Date: 2019-10